Evidence map›Paper›PMID 11581376›Full record

ArticleJournal of virology2001

Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.

P R Gorry, G Bristol, J A Zack, K Ritola, R Swanstrom, C J Birch, J E Bell, N Bannert, K Crawford, H Wang and 5 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 169 papers.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed
4.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 266 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Animal models for studies of HIV-1 brain reservoirs.Journal of leukocyte biology · 2022
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral Eradication.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2019
    Review
  18. Article
  19. Article
  20. Article

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 4 countries.

P R GorryDepartment of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
G Bristol
J A Zack
K Ritola
R Swanstrom
C J Birch
J E Bell
N Bannert
K Crawford
H Wang
D Schols
E De Clercq
K Kunstman
S M Wolinsky
D Gabuzda
Dana-Farber Cancer Institute · USBlack AIDS Institute · USNorthwestern University · USUniversity of North Carolina at Chapel Hill · USKU Leuven · BEPediatrics and Genetics · USRega Institute for Medical Research · BEUniversity of Edinburgh · GBVictorian Infectious Diseases Reference Laboratory · AU

Funding

MULTICENTER AIDS COHORT STUDYU01AI035039 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOLINSKY, STEVEN M · 1993 to 2018
$66.4M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MITSUYASU, RONALD T. · 1991 to 2018
$39.9M
DFCI-BIDMC-CH CENTER FOR AIDS RESEARCHP30AI028691 · NIAID · DANA-FARBER CANCER INSTITUTE · PI SODROSKI, JOSEPH G · 1989 to 2003
$6.2M
Molecular Biology of Viral Diseases Predoctoral Training GrantT32AI007419 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Mark T Heise, CARY A MOODY · 1993 to 2026
$4.7M
GREAT LAKES REGIONAL CENTER FOR AIDS RESEARCHP30CA079458 · NCI · NORTHWESTERN UNIVERSITY · PI NEATON, JAMES DENNIS · 1998 to 2002
$3.7M
Biological properties of HIV-1 V3 evolutionary variantsR37AI044667 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SWANSTROM, RONALD I · 2005 to 2014
$3.4M
CHEMOKINE RECEPTORS IN HIV1 INFECTION OF THE CNSR01NS037277 · NINDS · DANA-FARBER CANCER INSTITUTE · PI GABUZDA, DANA H. · 1998 to 2006
$2.9M
IN VIVO PATHOGENESIS OF HIV1R37AI036059 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZACK, JEROME A. · 1998 to 2007
$2.8M
Immune Reconstitution Following HIV InfectionR01AI036554 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZACK, JEROME A. · 1994 to 2006
$2.2M
ROLE OF APOPTOSIS IN HIV-1 DEMENTIAR01NS035734 · NINDS · DANA-FARBER CANCER INSTITUTE · PI GABUZDA, DANA H. · 1996 to 2003
$1.4M
UNC CENTER FOR AIDS RESEARCHP30HD037260 · NICHD · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI SWANSTROM, RONALD I · 1998 to 2000
$1.2M
BIOLOGICAL PROPERTIES OF HIV1 V3 EVOLUTIONARY VARIANTSR01AI044667 · NIAID · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI SWANSTROM, RONALD I · 1999 to 2002
$800k
NCI NIH HHS CA79458NIAID NIH HHS AI28691NIAID NIH HHS AI28697NIAID NIH HHS AI36059NIAID NIH HHS AI36554NIAID NIH HHS AI44667NIAID NIH HHS P30 AI028691NIAID NIH HHS P30 AI028697NIAID NIH HHS R01 AI036554NIAID NIH HHS R01 AI044667NIAID NIH HHS R37 AI036059NIAID NIH HHS R37 AI044667NIAID NIH HHS R56 AI044667NIAID NIH HHS T32 AI007419NIAID NIH HHS T32-AI07419NIAID NIH HHS U01 AI035039NIAID NIH HHS U01 AI35039NICHD NIH HHS HD37260NIDA NIH HHS DA13127NINDS NIH HHS NS35734NINDS NIH HHS NS37277NINDS NIH HHS R01 NS035734NINDS NIH HHS R01 NS037277
6 · The paper itself

Abstract

The viral determinants that underlie human immunodeficiency virus type 1 (HIV-1) neurotropism are unknown, due in part to limited studies on viruses isolated from brain. Previous studies suggest that brain-derived viruses are macrophage tropic (M-tropic) and principally use CCR5 for virus entry. To better understand HIV-1 neurotropism, we isolated primary viruses from autopsy brain, cerebral spinal fluid, blood, spleen, and lymph node samples from AIDS patients with dementia and HIV-1 encephalitis. Isolates were characterized to determine coreceptor usage and replication capacity in peripheral blood mononuclear cells (PBMC), monocyte-derived macrophages (MDM), and microglia. Env V1/V2 and V3 heteroduplex tracking assay and sequence analyses were performed to characterize distinct variants in viral quasispecies. Viruses isolated from brain, which consisted of variants that were distinct from those in lymphoid tissues, used CCR5 (R5), CXCR4 (X4), or both coreceptors (R5X4). Minor usage of CCR2b, CCR3, CCR8, and Apj was also observed. Primary brain and lymphoid isolates that replicated to high levels in MDM showed a similar capacity to replicate in microglia. Six of 11 R5 isolates that replicated efficiently in PBMC could not replicate in MDM or microglia due to a block in virus entry. CD4 overexpression in microglia transduced with retroviral vectors had no effect on the restricted replication of these virus strains. Furthermore, infection of transfected cells expressing different amounts of CD4 or CCR5 with M-tropic and non-M-tropic R5 isolates revealed a similar dependence on CD4 and CCR5 levels for entry, suggesting that the entry block was not due to low levels of either receptor. Studies using TAK-779 and AMD3100 showed that two highly M-tropic isolates entered microglia primarily via CXCR4. These results suggest that HIV-1 tropism for macrophages and microglia is restricted at the entry level by a mechanism independent of coreceptor specificity. These findings provide evidence that M-tropism rather than CCR5 usage predicts HIV-1 neurotropism.

Indexed as

Amino Acid SequenceBrainCD4 AntigensGene Products, envHIV-1HumansLeukocytes, MononuclearLymphoid TissueMacrophagesMicrogliaMolecular Sequence DataPolymerase Chain ReactionReceptors, CCR5Receptors, CXCR4Receptors, HIVVirus ReplicationCD4 AntigensGene Products, envReceptors, CCR5Receptors, CXCR4Receptors, HIV

Identifiers

PMID11581376
PMCPMC114582
OpenAlexW2154142064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.